FDA Approves Covid-19 Booster for ages 12-15: Here’s What You Need To Know

photo+courtesy+of+Flickr

photo courtesy of Flickr

Camilla Moran, Journalism Class Reporter & Staff Editor

On January third, 2022, the FDA (Food and Drug Administration) approved the Pfizer-BioTech booster shot to be administered to ages 12-15. As COVID-19 cases hit record numbers in the US, including children, more efforts have been made to protect kids against this terrible virus.

The FDA has shortened the timing of when to give Pfizer’s booster shots from six months to five months after the initial series of shots for everyone over age 12, based on Israeli research.

“This booster dose will provide optimized protection against COVID-19 and the Omicron variant. I encourage all parents to keep their children up to date with CDC’s COVID-19 vaccine recommendations,” CDC Director Dr. Rochelle Walensky said in a statement on January 5th.

Not only has there been a breakthrough with the vaccine for ages 12-15, but children ages 5-11 who are immunocompromised, are recommended to receive a third covid vaccine dose, 28 days after they’ve received their 2nd dose.

“These additional data enabled the FDA to reassess the benefits and risks of the use of a booster in the younger adolescent population in the setting of the current surge in COVID-19 cases. The data shows there are no new safety concerns following a booster in this population,” the FDA said.

Pfizer-BioNTech’s vaccine is currently the only vaccine authorized for young teens and adolescents. Both the vaccine and the boosters have been a breakthrough for adolescents and teens. Kids from 12-15 can now be protected by a global pandemic crashing through the world.